| scholarly article | Q13442814 |
| P50 | author | Pavankumar Tandra | Q60173806 |
| P2093 | author name string | Mojtaba Akhtari | |
| Shiksha Kedia | |||
| Vijaya Raj Bhatt | |||
| Radwa A El Behery | |||
| Sandeep Kumar Rajan | |||
| P2860 | cites work | Cryoglobulins | Q24673191 |
| Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma | Q27478232 | ||
| Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection | Q27490427 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis | Q33337510 | ||
| Treatment of hepatitis C related thrombocytopenia with interferon alpha | Q33340288 | ||
| Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection | Q33341932 | ||
| Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis | Q33344948 | ||
| Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases | Q33346990 | ||
| Hematologic disorders associated with hepatitis C virus infection and their management | Q33349378 | ||
| Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. | Q33359563 | ||
| Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. | Q33363143 | ||
| Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection | Q33363160 | ||
| Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability | Q47717799 | ||
| Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases | Q47888020 | ||
| Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. | Q50559814 | ||
| Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. | Q50579047 | ||
| Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. | Q50957005 | ||
| Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas | Q57718877 | ||
| Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia | Q61873087 | ||
| Hepatitis-associated aplastic anemia | Q73199949 | ||
| Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases | Q74097228 | ||
| Peripheral blood count abnormalities among patients with hepatitis C in the United States | Q77150218 | ||
| Peripheral blood count abnormalities among patients with hepatitis C in the United States | Q77823647 | ||
| Hepatitis C virus and liver transplantation | Q79428474 | ||
| Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function | Q83366487 | ||
| Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences | Q84073824 | ||
| Severe autoimmune neutropenia and thrombopenia associated with chronic C hepatitis: effect of antiviral therapy | Q33366048 | ||
| Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura | Q33366747 | ||
| Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia | Q33368703 | ||
| Management of the hematologic complications of hepatitis C therapy | Q33368815 | ||
| Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature. | Q33369742 | ||
| Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia | Q33372989 | ||
| Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease | Q33377126 | ||
| Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. | Q33377599 | ||
| Viral-associated immune thrombocytopenic purpura | Q33382383 | ||
| Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases | Q33383653 | ||
| Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection | Q33386712 | ||
| Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review | Q33391641 | ||
| The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results | Q33392295 | ||
| Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia | Q33396388 | ||
| Causes of thrombocytopenia in chronic hepatitis C viral infection | Q33399654 | ||
| Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia | Q33402924 | ||
| Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, Child's status and institution of specific treatment for hepatitis C with success. | Q33404092 | ||
| A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? | Q33496422 | ||
| Thrombocytopenia associated with hepatitis C viral infection | Q33497636 | ||
| Platelet-associated IgM elevated in patients with chronic hepatitis C contains no anti-platelet autoantibodies | Q33500979 | ||
| Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. | Q33502832 | ||
| Autoimmune thrombocytopenia associated with hepatitis C virus infection | Q33502899 | ||
| Aplastic anemia associated with interferon alpha 2a in a patient with chronic hepatitis C virus infection: a case report. | Q34078325 | ||
| Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy | Q34314762 | ||
| Hepatitis C virus and non-Hodgkin's lymphoma 10 years later | Q34405911 | ||
| Marginal zone-related neoplasms of splenic and nodal origin | Q35054456 | ||
| Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. | Q35629704 | ||
| Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies | Q35911859 | ||
| Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. | Q36204525 | ||
| Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection | Q36231193 | ||
| Normal lymphocyte development but delayed humoral immune response in CD81-null mice | Q36377129 | ||
| Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes | Q36684233 | ||
| Drug-induced anti-factor VIII antibodies: a systematic review. | Q36773436 | ||
| Extrahepatic manifestations of chronic HCV infection | Q36780779 | ||
| Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes | Q37356991 | ||
| Autoimmune neutropenia in adults. | Q37416788 | ||
| Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium | Q37656186 | ||
| Correlation of viral load with bone marrow and hematological changes in pale patients with chronic hepatitis C virus | Q38857469 | ||
| Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy | Q40317378 | ||
| High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. | Q41519138 | ||
| Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10, and GM-CSF. | Q42810247 | ||
| Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis | Q42914687 | ||
| Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma | Q42978526 | ||
| Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. | Q42982816 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas | Q42986628 | ||
| Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. | Q42987134 | ||
| Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? | Q42987380 | ||
| Hepatitis C virus infection in acquired aplastic anemia | Q42988531 | ||
| Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience | Q42990067 | ||
| No relationship between hepatitis C infection and risk of myeloid malignancy. | Q42991760 | ||
| Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center | Q42992613 | ||
| No association between hepatitis C and B-cell lymphoma | Q42992786 | ||
| Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility | Q42994250 | ||
| Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus | Q42998123 | ||
| Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. | Q42998904 | ||
| Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process | Q42999023 | ||
| Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate | Q42999332 | ||
| Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient | Q43000192 | ||
| Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. | Q43000908 | ||
| Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. | Q43033054 | ||
| Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. | Q43035212 | ||
| The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis | Q43035602 | ||
| Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection | Q43038794 | ||
| Lack of evidence for a role of HCV in hepatitis-associated aplastic anaemia | Q43041329 | ||
| Additional neoplasms and HCV infection in low-grade lymphoma of MALT type | Q44021092 | ||
| A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy | Q44150570 | ||
| Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group | Q44244755 | ||
| Severe neutropenia in patients with chronic hepatitis C: a benign condition | Q44432957 | ||
| Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. | Q44911029 | ||
| Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus | Q45332364 | ||
| Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. | Q45377393 | ||
| Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy | Q45400999 | ||
| Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs | Q45420769 | ||
| Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias | Q45526873 | ||
| Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection | Q45553745 | ||
| Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study | Q45723848 | ||
| Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. | Q45734023 | ||
| Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation | Q45737952 | ||
| The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection | Q45738333 | ||
| T(14;18) translocation in chronic hepatitis C virus infection | Q45744785 | ||
| Pure red cell aplasia responsive to interferon-alpha in a patient with hepatitis C virus infection | Q45751312 | ||
| Autoimmune thrombocytopenia and hepatitis C virus infection | Q45765974 | ||
| P433 | issue | Suppl 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| virology | Q7215 | ||
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | S179-92 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | International Journal of Preventive Medicine | Q15817466 |
| P1476 | title | Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection | |
| P478 | volume | 5 |
Search more.